Morphological and functional characterization of a specific marker for lymphatic vessels.

淋巴管特定标记物的形态和功能特征。

基本信息

  • 批准号:
    14207001
  • 负责人:
  • 金额:
    $ 27.54万
  • 依托单位:
  • 依托单位国家:
    日本
  • 项目类别:
    Grant-in-Aid for Scientific Research (A)
  • 财政年份:
    2002
  • 资助国家:
    日本
  • 起止时间:
    2002 至 2003
  • 项目状态:
    已结题

项目摘要

A specific marker for mouse lymphatic vessels has been characterized morphologically and functionally using a rat monoclonal antibody, LA102. 1.Specificity of LA102 antibody and tissue distribution of its antigen : (1)LA102 recognized mouse lymphatic vessels, but not blood vessels. (2)The antigen recognized by LA102 was localized on both luminal-and basal-sick cell membrane of lymphatic endothelium and was also highly condensed on the pinocytic or transport vesicle membrane. (3)LA102 positive endothelial cells were isolated from a benign lymphangioma and established as a cell line. 2.Immunobiological characterization of the LA102 antigen : (1)The isotype of LA102 antibody was rat IgG2b,κ. (2)The LA102 antigen was a glycoprotein with a molecular size of 25-27kDa. (3)LA102 antigen was also expressed on mainly T lymphocytes and cerebral tissues. 3.Molecular and genetical characterization of LA102 antigen : (1)LC-MASS analyzes revealed that LA102 antigen has a similar amino acid sequence to CD90 molecule. (2)Genetical analyzes of LA102 antigen have been underway comparing with CD90 and some other related molecules (such as cell adhesion molecules and chemokines). 4.Functional characterization of LA102 antigen : (1)Several experimental models for cell migration from the peritoneal cavity have been established. The diaphragm and omentum were the main lymphatic routes from the peritoneal cavity. (2)In an inflammatory model, LA102 antibody seemed to inhibit cell binding to various tissues, such as the liver, thymus, lymph nodes. These results suggest that LA102 might play an important role in the lymphoid cell migration and some transporting mechanisms through lymphatics under both normal and pathological conditions.
小鼠淋巴管的特异性标记物已经使用大鼠单克隆抗体LA 102在形态学和功能上表征。1. LA 102抗体的特异性及其抗原的组织分布:(1)LA 102识别小鼠淋巴管,不识别血管;(2)LA 102识别的抗原定位于淋巴管内皮细胞的腔病细胞膜和基底病细胞膜上,并高度浓缩于胞饮细胞膜或转运囊泡膜上。(3)从一良性淋巴管瘤组织中分离出LA 102阳性的内皮细胞,建立了细胞系。2. LA 102抗原的免疫生物学特性:(1)LA 102抗体的同种型为大鼠IgG 2b,κ。(2)LA 102抗原是一种糖蛋白,分子量为25- 27 kDa。(3)LA 102抗原主要表达于T淋巴细胞和脑组织。3. LA 102抗原的分子和遗传学特征:(1)LC-MASS分析表明LA 102抗原与CD 90分子具有相似的氨基酸序列。(2)LA 102抗原与CD 90及其他相关分子(如细胞粘附分子、趋化因子)的遗传学比较研究正在进行中。4. LA 102抗原的功能特性:(1)建立了几种细胞从腹腔迁移的实验模型。膈和网膜是腹膜腔的主要淋巴途径。(2)In在炎症模型中,LA 102抗体似乎抑制细胞与各种组织如肝、胸腺、淋巴结的结合。这些结果表明,在正常和病理条件下,LA 102可能在淋巴细胞迁移和通过淋巴管的一些转运机制中发挥重要作用。

项目成果

期刊论文数量(22)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
M.Murai et al.: "Peyer's patch is the essential site in initiating murine acute and lethal graft-versus-host reaction."Nature Immunol.. 4(2). 154-160 (2003)
M.Murai 等人:“派尔氏集结是引发小鼠急性和致命的移植物抗宿主反应的重要部位。”《自然免疫学》4(2)。
  • DOI:
  • 发表时间:
  • 期刊:
  • 影响因子:
    0
  • 作者:
  • 通讯作者:
S.FuJimura et al.: "Spontaneous increase of plasma-like cells with high GANP expression in the extrafollicular region of lymphoid organs of autoimmune-prone mice."J.Autoimmunlty. 20. 291-301 (2003)
S.FuJimura 等人:“在自身免疫倾向小鼠的淋巴器官滤泡外区域,具有高 GANP 表达的浆样细胞自发增加。”J.Autoimmunlty。
  • DOI:
  • 发表时间:
  • 期刊:
  • 影响因子:
    0
  • 作者:
  • 通讯作者:
S.Morikawa et al.: "Abnormalities of basement membrane on blood vessels and endothelial sprouts in tumors."Am.J.Pathol.. 163(5). 1801-1815 (2003)
S.Morikawa 等人:“肿瘤中血管和内皮芽的基底膜异常。”Am.J.Pathol.. 163(5)。
  • DOI:
  • 发表时间:
  • 期刊:
  • 影响因子:
    0
  • 作者:
  • 通讯作者:
T.Ezaki et al.: "Morphological and functional changes in lymphatics and microcirculatory systems at local inflammatory sites. (in Japanese)"Bulletin of Medical Research Institute Tokyo Women's Medical University. 23. 7-8 (2003)
T.Ezaki等人:“局部炎症部位淋巴管和微循环系统的形态和功能变化。(日语)”东京女子医科大学医学研究所通报。
  • DOI:
  • 发表时间:
  • 期刊:
  • 影响因子:
    0
  • 作者:
  • 通讯作者:
T.Ito et al.: "Defective B1 cell homing to the peritoneal cavity and preferential recruitment of B1 cells in the target organs in a murine model for SLE."J.Immunol.. 172. 3628-3634 (2004)
T.Ito 等人:“在 SLE 小鼠模型中,有缺陷的 B1 细胞归巢至腹膜腔,并在靶器官中优先招募 B1 细胞。”J.Immunol.. 172. 3628-3634 (2004)
  • DOI:
  • 发表时间:
  • 期刊:
  • 影响因子:
    0
  • 作者:
  • 通讯作者:
{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

EZAKI Taichi其他文献

EZAKI Taichi的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('EZAKI Taichi', 18)}}的其他基金

Reconstruction of the normal vasculature for the strategy of new cancer therapy.
重建正常脉管系统以制定新的癌症治疗策略。
  • 批准号:
    24659904
  • 财政年份:
    2012
  • 资助金额:
    $ 27.54万
  • 项目类别:
    Grant-in-Aid for Challenging Exploratory Research
Verification of the relationship between fat cells and lymphangiogenesis by using a benign lymphangioma model
利用良性淋巴管瘤模型验证脂肪细胞与淋巴管生成之间的关系
  • 批准号:
    19390053
  • 财政年份:
    2007
  • 资助金额:
    $ 27.54万
  • 项目类别:
    Grant-in-Aid for Scientific Research (B)
Mechanisms for the collection of cells by lymphatics
淋巴管收集细胞的机制
  • 批准号:
    12670020
  • 财政年份:
    2000
  • 资助金额:
    $ 27.54万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
A morphological and functional study on the development and regeneration of lymphatic vessels.
淋巴管发育和再生的形态和功能研究。
  • 批准号:
    05670018
  • 财政年份:
    1993
  • 资助金额:
    $ 27.54万
  • 项目类别:
    Grant-in-Aid for General Scientific Research (C)

相似海外基金

Unravelling the role of cellular microvesicles on lymphatic vessel function
揭示细胞微泡对淋巴管功能的作用
  • 批准号:
    RGPIN-2016-05331
  • 财政年份:
    2022
  • 资助金额:
    $ 27.54万
  • 项目类别:
    Discovery Grants Program - Individual
Metabolic mechanisms controlling lymphatic vessel formation
控制淋巴管形成的代谢机制
  • 批准号:
    10608206
  • 财政年份:
    2022
  • 资助金额:
    $ 27.54万
  • 项目类别:
Insulin regulation of lymphatic vessel integrity
胰岛素对淋巴管完整性的调节
  • 批准号:
    10683800
  • 财政年份:
    2022
  • 资助金额:
    $ 27.54万
  • 项目类别:
Lymphatic vessel function in atherosclerosis
动脉粥样硬化中的淋巴管功能
  • 批准号:
    447423
  • 财政年份:
    2021
  • 资助金额:
    $ 27.54万
  • 项目类别:
    Operating Grants
Unravelling the role of cellular microvesicles on lymphatic vessel function
揭示细胞微泡对淋巴管功能的作用
  • 批准号:
    RGPIN-2016-05331
  • 财政年份:
    2021
  • 资助金额:
    $ 27.54万
  • 项目类别:
    Discovery Grants Program - Individual
CAREER: Deciphering the nanoparticle-lymphatic vessel interface for modulating immunity
职业:破译纳米颗粒-淋巴管界面以调节免疫力
  • 批准号:
    2047017
  • 财政年份:
    2021
  • 资助金额:
    $ 27.54万
  • 项目类别:
    Continuing Grant
Elucidating the organ-specific lymphatic vessel development
阐明器官特异性淋巴管的发育
  • 批准号:
    20K17072
  • 财政年份:
    2020
  • 资助金额:
    $ 27.54万
  • 项目类别:
    Grant-in-Aid for Early-Career Scientists
Unravelling the role of cellular microvesicles on lymphatic vessel function
揭示细胞微泡对淋巴管功能的作用
  • 批准号:
    RGPIN-2016-05331
  • 财政年份:
    2020
  • 资助金额:
    $ 27.54万
  • 项目类别:
    Discovery Grants Program - Individual
Unravelling the role of cellular microvesicles on lymphatic vessel function
揭示细胞微泡对淋巴管功能的作用
  • 批准号:
    RGPIN-2016-05331
  • 财政年份:
    2019
  • 资助金额:
    $ 27.54万
  • 项目类别:
    Discovery Grants Program - Individual
Pathways Regulating Lymphatic Vessel Permeability and Valve Formation
调节淋巴管渗透性和瓣膜形成的途径
  • 批准号:
    10599157
  • 财政年份:
    2019
  • 资助金额:
    $ 27.54万
  • 项目类别:
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了